Post-translational regulation of L-glutamic acid decarboxylase in the brain

Neurochemical Research

Volumn 33, Issue 8, 2008, Pages 1459-1465

  Wei, Jianning ^a   Wu, Jang Yen ^a  

^a FLORIDA ATLANTIC UNIVERSITY   (United States)

Author keywords

Calpain; GAD65; GAD67; Palmitoylation; Phosphorylation; Post translational modification; Truncated GAD

Indexed keywords

4 AMINOBUTYRIC ACID; CALPAIN; GLUTAMATE DECARBOXYLASE 65; GLUTAMATE DECARBOXYLASE 67; GLUTAMIC ACID;

AMINO ACID SEQUENCE; ENZYME ACTIVITY; ENZYME REGULATION; HUMAN; NEUROTRANSMISSION; NONHUMAN; PALMITOYLATION; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; PROTEIN PROCESSING; REVIEW;

AMINO ACID SEQUENCE; ANIMALS; BRAIN; GAMMA-AMINOBUTYRIC ACID; GLUTAMATE DECARBOXYLASE; HUMANS; ISOENZYMES; MOLECULAR SEQUENCE DATA; PROTEIN PROCESSING, POST-TRANSLATIONAL; SEQUENCE ALIGNMENT;

EID: 46249093626     PISSN: 03643190     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11064-008-9600-5     Document Type: Review

References (55)

1. Bu DF, Erlander MG, Hitz BC et al (1992) Two human glutamate decarboxylases, 65-kDa GAD and 67-kDa GAD, are each encoded by a single gene. Proc Natl Acad Sci USA 89:2115-2119
2. Tian N, Petersen C, Kash S et al (1999) The role of the synthetic enzyme GAD65 in the control of neuronal gamma-aminobutyric acid release. Proc Natl Acad Sci USA 96:12911-12916
3. Kaufman DL, Houser CR, Tobin A (1991) Two forms of the aminobutyric acid synthetic enzyme glutamate decarboxylase have distinct intraneuronal distribution and cofactor interaction. J Neurochem 56:720-723
4. Owens D, Kriegstein A (2002) Is there more to GABA than synaptic inhibition? Nat Rev Neurosci 3:715-727
5. Fenalti G, Law RH, Buckle AM et al (2007) GABA production by glutamic acid decarboxylase is regulated by a dynamic catalytic loop. Nat Struct Mol Biol 14:280-286
6. Asada H, Kawamura Y, Maruyama K et al (1997) Cleft palate and decreased brain gamma-aminobutyric acid in mice lacking the 67-kDa isoform of glutamic acid decarboxylase. Proc Natl Acad Sci USA 94:6496-6499
7. Asada H, Kawamura Y, Maruyama K et al (1996) Mice lacking the 65 kDa isoform of glutamic acid decarboxylase (GAD65) maintain normal levels of GAD67 and GABA in their brains but are susceptible to seizures. Biochem Biophys Res Commun 229:891-895
8. Hsu CC, Davis KM, Jin H et al (2000) Association of l-glutamic acid decarboxylase to the 70-kDa heat shock protein as a potential anchoring mechanism to synaptic vesicles. J Biol Chem 275:20822-20828
9. Jin H, Wu H, Osterhaus G et al (2003) Demonstration of functional coupling between gamma-aminobutyric acid (GABA) synthesis and vesicular GABA transport into synaptic vesicles. Proc Natl Acad Sci USA 100:4293-4298
10. Tian N, Petersen C, Kash S et al (1999) The role of the synthetic enzyme GAD65 in the control of neuronal gamma-aminobutyric acid release. Proc Natl Acad Sci USA 96:12911-12916
11. Luo J, Kaplitt MG, Fitzsimons HL et al (2002) Subthalamic GAD gene therapy in a Parkinson's disease rat model. Science 298:425-429
12. Deng YP, Albin RL, Penney JB et al (2004) Differential loss of striatal projection systems in Huntington's disease: a quantitative immunohistochemical study. J Chem Neuroanat 27:143-164
13. Soghomonian JJ, Laprade N (1997) Glutamate decarboxylase (GAD67 and GAD65) gene expression is increased in a subpopulation of neurons in the putamen of Parkinsonian monkeys. Synapse 27:122-132
14. Solimena M, De Camilli P (1991) Autoimmunity to glutamic acid decarboxylase (GAD) in Stiff-Man syndrome and insulin-dependent diabetes mellitus. Trends Neurosci 14:452-457
15. Chattopadhyay S, Ito M, Cooper JD et al (2002) An autoantibody inhibitory to glutamic acid decarboxylase in the neurodegenerative disorder Batten disease. Hum Mol Gen 11:1421-1431
16. Stephenson DT, Li Q, Simmons C et al (2005) Expression of GAD65 and GAD67 immunoreactivity in MPTP-treated monkeys with or without l-DOPA administration. Neurobiol Dis 20:347-359
17. Freichel C, Potschka H, Ebert U et al (2006) Acute changes in the neuronal expression of GABA and glutamate decarboxylase isoforms in the rat piriform cortex following status epilepticus. Neuroscience 141:2177-2194
18. Guidotti A, Auta J, Davis JM et al (2000) Decrease in reelin and glutamic acid decarboxylase67 (GAD67) expression in schizophrenia and bipolar disorder: a postmortem brain study. Arch Gen Psychiatry 57:1061-1069
19. Impagnatiello F, Guidotti AR, Pesold C et al (1998) A decrease of reelin expression as a putative vulnerability factor in schizophrenia. Proc Natl Acad Sci USA 95:15718-15723
20. Bao J, Wai Yiu C, Jang-Yen W (1995) Brain l-glutamate decarboxylase: inhibition by phosphorylation and activation by dephosphorylation. J Biol Chem 270:6464-6467
21. Hsu CC, Thomas C, Chen W et al (1999) Role of synaptic vesicle proton gradient and protein phosphorylation on ATP-mediated activation of membrane-associated brain glutamate decarboxylase. J Biol Chem 274:24366-24371
22. Wei JN, Davis KM, Wu H et al (2004) Protein phosphorylation of human brain glutamic acid decarboxylase (GAD)65 and GAD67 and its physiological implications. Biochemistry 43:6182-6189
23. Battaini F, Pascale A (2005) Protein kinase C signal transduction regulation in physiological and pathological aging. Ann NY Acad Sci 1057:177-192
24. Khasar SG, Lin YH, Martin A et al (1999) A novel nociceptor signaling pathway revealed in protein kinase C epsilon mutant mice. Neuron 24:253-260
25. Saitoh N, Hori T,Takahashi T (2001) Activation of the epsilon isoform of protein kinase C in the mammalian nerve terminal. Proc Natl Acad Sci USA 98:14017-14021
26. Pastorino L, Colciaghi F, Gardoni F et al (2000) (+)-MCPG induces PKCepsilon translocation in cortical synaptosomes through a PLD-coupled mGluR. Eur J Neurosci 12:1310-1318
27. Choi DS, Wang D, Yu GQ et al (2006) PKCepsilon increases endothelin converting enzyme activity and reduces amyloid plaque pathology in transgenic mice. Proc Natl Acad Sci USA 103:8215-8220
28. Prekeris R, Mayhew MW, Cooper JB et al (1996) Identification and localization of an actin-binding motif that is unique to the epsilon isoform of protein kinase C and participates in the regulation of synaptic function. J Cell Biol 132:77-90
29. Namchuk M, Lindsay L, Turck CW et al (1997) Phosphorylation of serine residues 3, 6, 10, and 13 distinguishes membrane anchored from soluble glutamic acid decarboxylase 65 and is restricted to glutamic acid decarboxylase 65alpha. J Biol Chem 272:1548-1557
30. Dietrich LE, Ungermann C (2004) On the mechanism of protein palmitoylation. EMBO Rep 5:1053-1057
31. Greaves J, Chamberlain L (2007) Palmitoylation-dependent protein sorting. J Cell Biol 176:249-254
32. Huang K, Yanai A, Kang R et al (2004) Huntingtin-interacting protein HIP14 is a palmitoyl transferase involved in palmitoylation and trafficking of multiple neuronal proteins. Neuron 44:977-986
33. el-Husseini Ael D, Bredt D (2002) Protein palmitoylation: a regulator of neuronal development and function. Nat Rev Neurosci 3:791-802
34. Kanaani J, Diacovo MJ, El-Husseini Ael D et al (2004) Palmitoylation controls trafficking of GAD65 from Golgi membranes to axon-specific endosomes and a Rab5a-dependent pathway to presynaptic clusters. J Cell Sci 117:2001-2013
35. Kanaani J, El-Husseini Ael D, Aguilera-Moreno A et al (2002) A combination of three distinct trafficking signals mediates axonal targeting and presynaptic clustering of GAD65. J Cell Biol 158:1229-1238
36. Smotrys JE, Linder ME (2004) Palmitoylation of intracellular signaling proteins: regulation and function. Annu Rev Biochem 73:559-587
37. Bond RW, Wyborski RJ, Gottlieb D (1990) Developmentally regulated expression of an exon containing a stop codon in the gene for glutamic acid decarboxylase. Proc Natl Acad Sci USA 87:8771-8775
38. Szabo G, Katarova Z,Greenspan R (1994) Distinct protein forms are produced from alternatively spliced bicistronic glutamic acid decarboxylase mRNAs during development. Mol Cell Biol 14:7535-7545
39. Connaughton VP, Dyer KD, Nadi NS et al (2001) The expression of GAD67 isoforms in zebrafish retinal tissue changes over the light/dark cycle. J Neurocytol 30:303-312
40. Buss K, Drewke C, Lohmann S et al (2001) Properties and interaction of heterologously expressed glutamate decarboxylase isoenzymes GAD(65 kDa) and GAD(67 kDa) from human brain with ginkgotoxin and its 5′-phosphate. J Med Chem 44:3166-3174
41. Wei J, Jin Y, Wu H et al (2003) Identification and functional analysis of truncated human glutamic acid decarboxylase 65. J Biomed Sci 10:617-624
42. Christgau S, Aanstoot HJ, Schierbeck H et al (1992) Membrane anchoring of the autoantigen GAD65 to microvesicles in pancreatic beta-cells by palmitoylation in the NH2-terminal domain. J Cell Biol 118:309-320
43. Wei J, Lin CH, Wu H et al (2006) Activity-dependent cleavage of brain glutamic acid decarboxylase 65 by calpain. J Neurochem 98:1688-1695
44. Goll DE, Thompson VF, Li H et al (2003) The calpain system. Physiol Rev 83:731-801
45. Wu HY, Lynch D (2006) Calpain and synaptic function. Mol Neurobiol 33:215-236
46. Branca D (2004) Calpain-related diseases. Biochem Biophys Res Commun 322:1098-1104
47. Nixon R (2003) The calpains in aging and aging-related diseases. Aging Res Rev 2:407-418
48. Lee MS, Kwon YT, Li M et al (2000) Neurotoxicity induces cleavage of p35 to p25 by calpain. Nature 405:360-364
49. Raynaud F, Marcilhac A (2006) Implication of calpain in neuronal apoptosis. A possible regulation of Alzheimer's disease. FEBS J 273:3437-3443
50. Crocker SJ, Smith PD, Jackson-Lewis V et al (2003) Inhibition of calpains prevents neuronal and behavioral deficits in an MPTP mouse model of Parkinson's disease. J Neurosci 23:4081-4091
51. Baekkeskov S, Aanstoot HJ, Christgau S et al (1990) Identification of the 64 K autoantigen in insulin-dependent diabetes as the GABA-synthesizing enzyme glutamic acid decarboxylase. Nature 347:151-156
52. Lohmann T, Hawa M, Leslie RD et al (2000) Immune reactivity to glutamic acid decarboxylase 65 in stiffman syndrome and type 1 diabetes mellitus. Lancet 356:31-35
53. Raju R, Foote J, Banga JP et al (2005) Analysis of GAD65 autoantibodies in Stiff-Person syndrome patients. J Immunol 175:7755-7762
54. Kim J, Namchuk M, Bugawan T et al (1994) Higher autoantibody levels and recognition of a linear NH2-terminal epitope in the autoantigen GAD65, distinguish stiff-man syndrome from insulin-dependent diabetes mellitus. J Exp Med 180:595-606
55. Lich JD, Elliott JF,Blum J (2000) Cytoplasmic processing is a prerequisite for presentation of an endogenous antigen by major histocompatibility complex class II proteins. J Exp Med 191:1513-1524